Royce & Associates LP Has $1.67 Million Stock Position in Aehr Test Systems $AEHR

Royce & Associates LP lowered its position in Aehr Test Systems (NASDAQ:AEHR) by 50.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,425 shares of the semiconductor company’s stock after selling 56,123 shares during the quarter. Royce & Associates LP’s holdings in Aehr Test Systems were worth $1,669,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AEHR. William Blair Investment Management LLC acquired a new stake in shares of Aehr Test Systems during the 3rd quarter valued at about $26,920,000. Kennedy Capital Management LLC bought a new position in Aehr Test Systems during the second quarter valued at approximately $5,751,000. Vanguard Group Inc. raised its position in Aehr Test Systems by 2.9% during the third quarter. Vanguard Group Inc. now owns 2,288,190 shares of the semiconductor company’s stock valued at $68,897,000 after acquiring an additional 65,444 shares in the last quarter. HighTower Advisors LLC lifted its stake in Aehr Test Systems by 485.1% in the third quarter. HighTower Advisors LLC now owns 78,340 shares of the semiconductor company’s stock valued at $2,359,000 after acquiring an additional 64,950 shares during the last quarter. Finally, Royal Bank of Canada grew its position in Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock worth $365,000 after acquiring an additional 36,364 shares in the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the stock. Lake Street Capital assumed coverage on shares of Aehr Test Systems in a report on Wednesday, December 17th. They set a “buy” rating on the stock. Zacks Research raised shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, December 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. William Blair upgraded Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research note on Monday. Finally, Craig Hallum reissued a “hold” rating on shares of Aehr Test Systems in a research note on Friday, January 9th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $21.00.

Aehr Test Systems Price Performance

AEHR stock opened at $40.49 on Friday. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of -134.96 and a beta of 2.22. The company has a 50-day moving average of $28.89 and a two-hundred day moving average of $26.36. Aehr Test Systems has a 52-week low of $6.27 and a 52-week high of $46.95.

Aehr Test Systems (NASDAQ:AEHR) last posted its quarterly earnings data on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.04. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%.The business had revenue of $9.88 million during the quarter, compared to analysts’ expectations of $11.45 million. Equities analysts expect that Aehr Test Systems will post 0.1 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Laura Oliphant sold 4,546 shares of the business’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $31.40, for a total transaction of $142,744.40. Following the transaction, the director owned 18,432 shares of the company’s stock, valued at approximately $578,764.80. The trade was a 19.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Rhea J. Posedel sold 13,998 shares of the company’s stock in a transaction on Friday, February 13th. The shares were sold at an average price of $30.02, for a total transaction of $420,219.96. Following the transaction, the director owned 456,979 shares of the company’s stock, valued at approximately $13,718,509.58. The trade was a 2.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 6.80% of the stock is owned by insiders.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.